Literature DB >> 23340849

Rational design of [Co(acacen)L2]+ inhibitors of protein function.

Lauren M Matosziuk1, Robert J Holbrook, Lisa M Manus, Marie C Heffern, Mark A Ratner, Thomas J Meade.   

Abstract

Cobalt(III) Schiff base complexes, such as [Co(acacen)L(2)](+), inhibit the function of Zn(II)-dependent proteins through dissociative exchange of the axial ligands with key histidine residues of the target protein. Consequently the efficacy of these compounds depends strongly on the lability of the axial ligands. A series of [Co(acacen)L(2)](+) complexes with various axial ligands was investigated using DFT to determine the kinetics and thermodynamics of ligand exchange and hydrolysis. Results showed excellent agreement with experimental data, indicating that axial ligand lability is determined by several factors: pK(a) of the axial ligand, the kinetic barrier to ligand dissociation, and the relative thermodynamic stability of the complexes before and after exchange. Hammett plots were constructed to determine if the kinetics and thermodynamics of exchange can be modulated by the addition of an electron-withdrawing group (EWG) to either the axial ligand itself or to the equatorial acacen ligand. Results predict that addition of an EWG to the axial ligand will shift the kinetics and thermodynamics so as to promote axial ligand exchange, while addition of an EWG to acacen will decrease axial ligand lability. These investigations will aid in the design of the next generation of [Co(acacen)L(2)](2+), allowing researchers to develop new, more effective inhibitors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23340849      PMCID: PMC3581327          DOI: 10.1039/c2dt32565a

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  22 in total

Review 1.  Advances in methods and algorithms in a modern quantum chemistry program package.

Authors:  Yihan Shao; Laszlo Fusti Molnar; Yousung Jung; Jörg Kussmann; Christian Ochsenfeld; Shawn T Brown; Andrew T B Gilbert; Lyudmila V Slipchenko; Sergey V Levchenko; Darragh P O'Neill; Robert A DiStasio; Rohini C Lochan; Tao Wang; Gregory J O Beran; Nicholas A Besley; John M Herbert; Ching Yeh Lin; Troy Van Voorhis; Siu Hung Chien; Alex Sodt; Ryan P Steele; Vitaly A Rassolov; Paul E Maslen; Prakashan P Korambath; Ross D Adamson; Brian Austin; Jon Baker; Edward F C Byrd; Holger Dachsel; Robert J Doerksen; Andreas Dreuw; Barry D Dunietz; Anthony D Dutoi; Thomas R Furlani; Steven R Gwaltney; Andreas Heyden; So Hirata; Chao-Ping Hsu; Gary Kedziora; Rustam Z Khalliulin; Phil Klunzinger; Aaron M Lee; Michael S Lee; Wanzhen Liang; Itay Lotan; Nikhil Nair; Baron Peters; Emil I Proynov; Piotr A Pieniazek; Young Min Rhee; Jim Ritchie; Edina Rosta; C David Sherrill; Andrew C Simmonett; Joseph E Subotnik; H Lee Woodcock; Weimin Zhang; Alexis T Bell; Arup K Chakraborty; Daniel M Chipman; Frerich J Keil; Arieh Warshel; Warren J Hehre; Henry F Schaefer; Jing Kong; Anna I Krylov; Peter M W Gill; Martin Head-Gordon
Journal:  Phys Chem Chem Phys       Date:  2006-06-12       Impact factor: 3.676

Review 2.  Design of targeting ligands in medicinal inorganic chemistry.

Authors:  Tim Storr; Katherine H Thompson; Chris Orvig
Journal:  Chem Soc Rev       Date:  2006-04-20       Impact factor: 54.564

3.  Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density.

Authors: 
Journal:  Phys Rev B Condens Matter       Date:  1988-01-15

4.  Specific inhibition of the transcription factor Ci by a cobalt(III) Schiff base-DNA conjugate.

Authors:  Ryan R Hurtado; Allison S Harney; Marie C Heffern; Robert J Holbrook; Robert A Holmgren; Thomas J Meade
Journal:  Mol Pharm       Date:  2012-01-20       Impact factor: 4.939

5.  Co2+ binding cysteine and selenocysteine: a DFT study.

Authors:  Riccardo Spezia; Guewen Tournois; Thierry Cartailler; Jeanine Tortajada; Yannick Jeanvoine
Journal:  J Phys Chem A       Date:  2006-08-10       Impact factor: 2.781

Review 6.  Essential viral and cellular zinc and iron containing metalloproteins as targets for novel antiviral and anticancer agents: implications for prevention and therapy of viral diseases and cancer.

Authors:  J A Fernandez-Pol; P D Hamilton; D J Klos
Journal:  Anticancer Res       Date:  2001 Mar-Apr       Impact factor: 2.480

7.  Inhibition of thermolysin and human alpha-thrombin by cobalt(III) Schiff base complexes.

Authors:  T Takeuchi; A Böttcher; C M Quezada; T J Meade; H B Gray
Journal:  Bioorg Med Chem       Date:  1999-05       Impact factor: 3.641

8.  Towards Antitumor Active trans-Platinum Compounds.

Authors:  Sheena M Aris; Nicholas P Farrell
Journal:  Eur J Inorg Chem       Date:  2009-04-01       Impact factor: 2.524

Review 9.  Boon and bane of metal ions in medicine.

Authors:  Katherine H Thompson; Chris Orvig
Journal:  Science       Date:  2003-05-09       Impact factor: 47.728

10.  A cobalt complex that selectively disrupts the structure and function of zinc fingers.

Authors:  A Y Louie; T J Meade
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

View more
  6 in total

1.  Light-activated protein inhibition through photoinduced electron transfer of a ruthenium(II)-cobalt(III) bimetallic complex.

Authors:  Robert J Holbrook; David J Weinberg; Mark D Peterson; Emily A Weiss; Thomas J Meade
Journal:  J Am Chem Soc       Date:  2015-03-02       Impact factor: 15.419

2.  Physical properties, ligand substitution reactions, and biological activity of Co(iii)-Schiff base complexes.

Authors:  A Paden King; Hendryck A Gellineau; Samantha N MacMillan; Justin J Wilson
Journal:  Dalton Trans       Date:  2019-05-07       Impact factor: 4.390

3.  Modulation of amyloid-β aggregation by histidine-coordinating Cobalt(III) Schiff base complexes.

Authors:  Marie C Heffern; Pauline T Velasco; Lauren M Matosziuk; Joseph L Coomes; Constantine Karras; Mark A Ratner; William L Klein; Amanda L Eckermann; Thomas J Meade
Journal:  Chembiochem       Date:  2014-06-24       Impact factor: 3.164

4.  Tuning cobalt(III) Schiff base complexes as activated protein inhibitors.

Authors:  Marie C Heffern; Viktorie Reichova; Joseph L Coomes; Allison S Harney; Elizabeth A Bajema; Thomas J Meade
Journal:  Inorg Chem       Date:  2015-09-02       Impact factor: 5.165

5.  Photoinduced electron transfer from PbS quantum dots to cobalt(III) Schiff base complexes: light activation of a protein inhibitor.

Authors:  Mark D Peterson; Robert J Holbrook; Thomas J Meade; Emily A Weiss
Journal:  J Am Chem Soc       Date:  2013-08-23       Impact factor: 15.419

6.  The First Dimeric Derivatives of the Glycopeptide Antibiotic Teicoplanin.

Authors:  Ilona Bereczki; Zsolt Szűcs; Gyula Batta; Tamás Milán Nagy; Eszter Ostorházi; Katalin E Kövér; Anikó Borbás; Pál Herczegh
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.